Gottlieb DJ, Sutrave G, Jiang W, Avdic S, et al. Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection and leukemia recurrence after allogeneic stem cell transplant. Am J Hematol 2022 May 12. doi: 10.1002/ajh.26594.
PMID: 35560045